1203 related articles for article (PubMed ID: 17145223)
1. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
2. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
3. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
5. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
[TBL] [Abstract][Full Text] [Related]
6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
7. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
8. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
[TBL] [Abstract][Full Text] [Related]
9. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
Chow SL; Peng JT; Okamoto MP; Heywood JT
Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS
Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
12. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
[TBL] [Abstract][Full Text] [Related]
14. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
15. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
18. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
Arora S; Clarke K; Srinivasan V; Gradman A
QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
[TBL] [Abstract][Full Text] [Related]
19. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
Kelesidis I; Mazurek J; Khullar P; Saeed W; Vittorio T; Zolty R
Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
[TBL] [Abstract][Full Text] [Related]
20. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]